respimmun.at

Welcome

Description

Faculty

Young Faculty

• Avian
• Bärnthaler
• Biasin
• Birnhuber
• Brčić
• Crnković
Douschan ⏩
• Foris
• Jandl
• Kovács
• Lindenmann
• Nagaraj
• Vesely

Students

Training

Publications

PhD Program
Congress (Retreat)

 

• Webmaster

The RESPImmun Young Faculty

Philipp DOUSCHAN, MD, PhD

Division of Pumonology, Department of Internal Medicine; Medical University of Graz, Auenbruggerplatz 15, A-8036 Graz; and Ludwig Boltzmann Institute for Lung and Vascular Research, Neue Stiftingstalstraße 6/VI, A-8010 Graz
phone: +43-316-385 12183, fax: +43-316-385 13578,  e-mail
websites: [RESPImmun] [MUG] [LBI]
• Profile     • Curriculum vitae     • PhD students     • Grants     • Publications ⏬    

List of publications:

10 most significant publications:

  1. Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H: Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality. Am J Respir Crit Care Med, 2018; 197(4):​509–516.
  2. Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE, Ghanim B, Klepetko W, Fruhwald F, Lassner D, Olschewski A, Olschewski H, Hassoun PM, Kwapiszewska G: Disconnect between Fibrotic Response and Right Ventricular Dysfunction. Am J Respir Crit Care Med, 2019; 199(12):​1550–1560.
  3. Douschan P, Kovacs G, Foris V, Kuehnelt-Leddihn M, Olschewski H: Imatinib for right heart failure in COPD. Pulm Circ, 2019; 19(1):​2045894018816974.
  4. Kovacs G, Douschan P, Maron BA, Condliffe R, Olschewski H: Mildly increased pulmonary arterial pressure: a new disease entity or just a marker of poor prognosis? Eur J Heart Fail, 2019; 21(9):​1057–1061.
  5. Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W: Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol, 2018; 272S:​63–68.
  6. Trieb M, Rainer F, Stadlbauer V, Douschan P, Horvath A, Binder L, Trakaki A, Knuplez E, Scharnagl H, Stojakovic T, Heinemann Á, Mandorfer M, Paternostro R, Reiberger T, Pitarch C, Amorós A, Gerbes A, Caraceni P, Alessandria C, Moreau R, Clària J, Marsche G, Stauber RE: HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol, 2020; 73(1):​113–120.
  7. Foris V, Kovacs G, Marsh LM, Bálint Z, Tötsch M, Avian A, Douschan P, Ghanim B, Klepetko W, Olschewski A, Olschewski H: CD133+ cells in pulmonary arterial hypertension. Eur Respir J, 2016; 48(2):​459–469.
  8. Kovacs G, Avian A, Foris V, Tscherner M, Kqiku X, Douschan P, Bachmaier G, Olschewski A, Matucci-Cerinic M, Olschewski H: Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension. PLoS One, 2016; 11(12):​e0168706.
  9. Lackner C, Spindelboeck W, Haybaeck J, Douschan P, Rainer F, Terracciano L, Haas J, Berghold A, Bataller R, Stauber RE: Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol, 2017; 66(3):​610–618.
  10. Aigelsreiter A, Neumann J, Pichler M, Halasz J, Zatloukal K, Berghold A, Douschan P, Rainer F, Stauber R, Haybaeck J, Denk H, Lackner C: Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis. Liver Int, 2017; 37(4):​600–610.